Probiotics in Radiation-treated Gynecologic Cancer

Probiotics in Radiation-treated Gynecologic Cancer

The aim of the current Project is to study the efficacy of a probiotic Product in reducing the symptoms of gastrointestinal toxicity linked to the irradiation of gynecologic cancer.

Inclusion Criteria:

• Women diagnosed with cancer in the small pelvis and waiting to receive radiotherapy either as a primary or as a secondary treatment following surgery. Chemotherapy may or may not be part of the treatment regimen.
• Age, older than 18 years old.
• Agreement for participation in the study by signed written informed consent.

Exclusion Criteria:

• Previously treated with irradiation of the pelvic area.
• Reluctance to refrain from using other probiotic products during the participation in the study.